EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Sustained Belinostat‐Induced Metabolic Response and Tolerability in Heavily Pretreated Relapsed/Refractory Angioimmunoblastic T‐Cell Lymphoma: A Case Report

Vassiliki Labropoulou, Evgenia Verigou, Eleni P. Kourea, Maria Liga, Dimitrios Tsokanas, Krisela‐Christina Valera, Alexandros Spyridonidis

Clinical Case Reports · 2026-04 · 14 (4)

DOI: 10.1002/ccr3.72186 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 25.03.2026. Verfasst von Vassiliki Labropoulou und 6 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angioimmunoblastic T‐cell lymphoma (AITL), a rare and aggressive subtype of peripheral T‐cell lymphoma (PTCL), often demonstrates resistance to standard therapies. The optimal therapeutic approach for relapsed/refractory (R/R) AITL remains therefore uncertain and challenging, with an unmet need for effective treatment options. Given the role of epigenetic alterations in AITL lymphomagenesis, the development of drugs targeting epigenetics may present a promising therapeutic approach. Belinostat, a histone deacetylase (HDAC) inhibitor, induced durable partial remission in heavily pretreated relapsed/refractory angioimmunoblastic T‐cell lymphoma, highlighting its potential as an effective therapeutic option when standard treatments and stem cell transplantation are unsuitable.

Zitieren

APA

Labropoulou, V., Verigou, E., Kourea, E. P., Liga, M., Tsokanas, D., Valera, K., & Spyridonidis, A. (2026). Sustained Belinostat‐Induced Metabolic Response and Tolerability in Heavily Pretreated Relapsed/Refractory Angioimmunoblastic T‐Cell Lymphoma: A Case Report. Clinical Case Reports, 14(4). https://doi.org/10.1002/ccr3.72186

Vancouver

Labropoulou V, Verigou E, Kourea EP, Liga M, Tsokanas D, Valera K, et al. Sustained Belinostat‐Induced Metabolic Response and Tolerability in Heavily Pretreated Relapsed/Refractory Angioimmunoblastic T‐Cell Lymphoma: A Case Report. Clinical Case Reports. 2026;14(4). doi:10.1002/ccr3.72186

BibTeX
@article{Labropoulou2026,
  author = {Labropoulou, Vassiliki and Verigou, Evgenia and Kourea, Eleni P. and Liga, Maria and Tsokanas, Dimitrios and Valera, Krisela‐Christina and Spyridonidis, Alexandros},
  title = {Sustained Belinostat‐Induced Metabolic Response and Tolerability in Heavily Pretreated Relapsed/Refractory Angioimmunoblastic T‐Cell Lymphoma: A Case Report},
  journal = {Clinical Case Reports},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1002/ccr3.72186}
}
Kostenlos starten →